D'ORONZO, STELLA
 Distribuzione geografica
Continente #
NA - Nord America 2.320
EU - Europa 496
AS - Asia 259
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 3.081
Nazione #
US - Stati Uniti d'America 2.316
SE - Svezia 220
CN - Cina 156
IT - Italia 81
VN - Vietnam 62
GB - Regno Unito 59
DE - Germania 34
FR - Francia 26
SG - Singapore 24
BE - Belgio 19
FI - Finlandia 18
IE - Irlanda 6
IL - Israele 6
NL - Olanda 6
UA - Ucraina 6
CZ - Repubblica Ceca 5
IN - India 5
CA - Canada 4
HK - Hong Kong 4
AL - Albania 3
DK - Danimarca 3
AU - Australia 2
CH - Svizzera 2
EE - Estonia 2
IR - Iran 2
NZ - Nuova Zelanda 2
AT - Austria 1
CL - Cile 1
ES - Italia 1
EU - Europa 1
HR - Croazia 1
HU - Ungheria 1
PL - Polonia 1
RU - Federazione Russa 1
Totale 3.081
Città #
Fairfield 347
Chandler 315
Nyköping 180
Ashburn 175
Woodbridge 158
Houston 157
Seattle 151
Cambridge 135
Wilmington 120
Ann Arbor 94
Dong Ket 60
Lawrence 49
Roxbury 46
Beijing 45
New York 39
Nanjing 35
Jacksonville 28
Des Moines 27
Inglewood 23
Brooklyn 22
Paris 21
Brussels 19
Bari 18
San Diego 17
Los Angeles 16
Dearborn 14
Princeton 12
Falls Church 11
London 10
Singapore 10
Guangzhou 9
Helsinki 9
Redwood City 9
Boardman 8
Jiaxing 7
Shenyang 7
Tianjin 7
Dublin 6
Nanchang 6
St Albans 6
Tel Aviv 6
Washington 6
Brno 5
Islington 5
Jinan 5
Milan 5
Pune 5
Changsha 4
Chicago 4
West Jordan 4
Xian 4
Edinburgh 3
Acton 2
Auckland 2
Brighton 2
Brisbane 2
Cancellara 2
Candela 2
Dallas 2
Falkenstein 2
Frederiksberg 2
Grafing 2
Grumo Appula 2
Hanoi 2
Hebei 2
Hefei 2
Kilburn 2
Marseille 2
Munich 2
Ningbo 2
Norwalk 2
Prescot 2
Qingdao 2
Stockholm 2
Taizhou 2
Tallinn 2
Taranto 2
Amsterdam 1
Ardabil 1
Assèmini 1
Atlanta 1
Bologna 1
Borås 1
Boydton 1
Budapest 1
Campi Salentina 1
Catanzaro 1
Cavenago di Brianza 1
Cedar Knolls 1
Cogliate 1
Como 1
Copenhagen 1
Düsseldorf 1
Ferrara 1
Forlì 1
Frankfurt am Main 1
Gostar 1
Groningen 1
Hangzhou 1
Hanover 1
Totale 2.557
Nome #
1,25(OH)2 vitamin D(3) contributes to osteoclast-like trans-differentiation of malignant plasma cells 204
Tumor-derived exosomes promote the in vitro osteotropism of melanoma cells by activating the SDF-1/CXCR4/CXCR7 axis. 107
Everolimus restrains the IL-17A-dependent osteoclast-like transdifferentiation of dendritic cells in multiple myeloma 103
Cancer treatment-induced bone loss (CTIBL): Pathogenesis and clinical implications. 101
Osteotropism of neuroendocrine tumors: Role of the CXCL12/ CXCR4 pathway in promoting EMT in vitro 98
Defective levels of both circulating dendritic cells and T-regulatory cells correlate with risk of recurrence in cutaneous melanoma 96
10-year patterns of recurrence from early breast cancer: Analyses of the AZURE (BIG 01/04) study of adjuvant zoledronic acid. 95
null 91
Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors 91
The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma. 90
Bone-sialoprotein (BSP), Dickkopf-1 (DKK1) and CXCR4 as potential biomarkers of breast cancer metastasis to bone: Analysis within the AZURE (BIG 01/04) study of adjuvant zoledronic acid. 88
Perspective in infertility: the ovarian stem cells 84
Dissection of major cancer gene variants in subsets of circulating tumor cells in advanced breast cancer. 81
Molecular Assessment of Ovarian Cancer and Translation to Clinical Management 81
The role of biomarkers in the management of bone-homing malignancies 80
Cutaneous metastasis as a primary presentation of a pulmonary enteric adenocarcinoma 78
In vitro differentiation of human oocyte-like cells from oogonial stem cells: single-cell isolation and molecular characterization 76
Management of metabolic adverse events of targeted therapies and immune checkpoint inhibitors in cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper 74
Ovarian cancer: Novel molecular aspects for clinical assessment 73
Cancer Treatment and Bone Health 72
Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression 71
Lenalidomide exerts cytostatic activity on melanoma cells by negative regulation of their cell cycle 70
Dual-procedural separation of CTCs in cutaneous melanoma provides useful information for both molecular diagnosis and prognosis 70
Ddx4+ Oogonial Stem Cells in Postmenopausal Women's Ovaries: A Controversial, Undefined Role 70
Bone Metastases from Solid Tumors: In Search of Predictive Biomarkers for Clinical Translation 66
Breast cancer: an update on treatment-related infertility 65
CORRIGENDUM to The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma 64
The value of biomarkers in bone metastasis 61
null 61
Metastatic bone disease: Pathogenesis and therapeutic options: Up-date on bone metastasis management 59
Bone Metastases; Clinical Aspects 58
In vitro generation of oocytes from ovarian stem cells (OSCs): In search of major evidence 55
DEAD-Box Helicase 4 (Ddx4)+ Stem Cells Sustain Tumor Progression in Non-Serous Ovarian Cancers 54
Medical Prevention and Treatment of Bone Metastases. 52
Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer 52
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015 52
Reply: Improved understanding of very small embryonic-like stem cells in adult mammalian ovary 45
In search of a bone metastasis (BM) gene signature in circulating tumour cells (CTCs) from stage IV breast cancer (BC) patients 43
Application of “omics” sciences to the prediction of bone metastases from breast cancer: State of the art 43
Pulmonary enteric adenocarcinoma: An overview 39
Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper 35
null 32
Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper 31
[Cell-based strategies: novel perspectives for cancer therapy]. FT Terapie cellulari in oncologia: recenti acquisizioni e sviluppi futuri 29
Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper 26
Bone metastases in hepatocellular carcinoma: an emerging issue 25
Metabolic disorders and gastroenteropancreatic-neuroendocrine tumors (GEP-NETs): How do they influence each other? An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper 25
Uterine carcinosarcoma: An overview 24
null 23
[Bone health in the oncologic patient]. FT La "bone health" nel paziente oncologico 23
Liquid biopsy in cervical cancer: Hopes and pitfalls 22
Correlation between targeted RNAseq signature of breast cancer CTCs and onset of bone-only metastases 20
The use of bisphosphonates to treat skeletal complications in solid tumours 18
Natural history of stage II/III breast cancer, bone metastasis and the impact of adjuvant zoledronate on distribution of recurrences 11
Fertility preservation techniques in cervical carcinoma 10
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update 8
Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations 7
Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper 5
MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view 4
Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group 4
Therapeutic approaches to myeloma bone disease: An evolving story 4
Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper 3
Polybrominated Diphenyl Ethers (PBDEs) and Human Health: Effects on Metabolism, Diabetes and Cancer 2
Totale 3.404
Categoria #
all - tutte 18.051
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.051


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020566 0 26 23 42 48 45 61 69 77 76 68 31
2020/2021807 29 43 50 161 127 69 41 48 36 59 42 102
2021/2022462 24 8 15 13 17 50 13 23 47 54 63 135
2022/2023781 106 124 67 55 74 95 23 79 111 4 26 17
2023/2024356 19 69 23 45 27 91 7 14 7 12 12 30
2024/202548 35 13 0 0 0 0 0 0 0 0 0 0
Totale 3.404